Acquired Factor XI Inhibitor in Systemic Lupus Erythematosus-Case Report and Literature Review

Seminars in Arthritis and Rheumatism

Volumn 39, Issue 1, 2009, Pages 61-65

  Bortoli, Rodrigo ^a   Monticielo, Odirlei A ^a   Chakr, Rafael M ^a   Palominos, Penélope E ^a   Rohsig, Liane M ^a   Kohem, Charles L ^a   Xavier, Ricardo M ^a   Brenol, João Carlos T ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

bleeding disorders; circulating anticoagulant; coagulopathy; factor XI; factor XI inhibitor; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 11; CEFEPIME; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISONE; PROTEIN ANTIBODY;

ABDOMINAL BLEEDING; ADULT; ANTIBODY PRODUCTION; ARTICLE; BLEEDING DISORDER; BLOOD ANALYSIS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; GYNECOLOGIC SURGERY; HUMAN; LABORATORY TEST; MEDICAL LITERATURE; OVARY DISEASE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSVAGINAL ECHOGRAPHY;

BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FACTOR XI; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; YOUNG ADULT;

EID: 67650961016     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2008.03.005     Document Type: Article

References (23)

1. Krieger H., Leddy J.P., and Breckenridge R.T. Studies on a circulating anticoagulant in systemic lupus erythematosus: evidence for inhibition of the function of activated plasma thromboplastin antecedent (factor XIa). Blood 46 2 (1975) 189-197
2. Castro O., Farber L.R., and Clyne L.P. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus. Ann Intern Med 77 4 (1972) 543-548
3. Salomon O., Zivelin A., Livnat T., Dardik R., Loewenthal R., Avishai O., et al. Prevalence, causes, and characterization of factor XI inhibitors in patients with inherited factor XI deficiency. Blood 101 12 (2003) 4783-4788
4. DiSabatino C.A., Clyne L.P., and Malawista S.E. A circulating anticoagulant directed against factor XIa in systemic lupus erythematosus. Arthritis Rheum 22 10 (1979) 1135-1138
5. Boggio L.N., and Green D. Acquired hemophilia. Rev Clin Exp Hematol 5 4 (2001) 389-404 quiz following 431.
6. Triplett D.A. Physiologic and pathologic inhibitors. Procedures for the Coagulation Laboratory, Educational Products Division of the American Society of Clinical Pathologists, Chicago (1981) 69-75
7. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 11 (1982) 1271-1277
8. Leone G., Accorra F., and Boni P. Circulating anticoagulant against factor XI and thrombocytopenia with platelet aggregation inhibition in systemic lupus erythematosus. Acta Haematol 58 4 (1977) 240-245
9. Blatt P.M., Yount W.J., Utsinger P.D., Korn J.H., Hadler N.M., and Roberts H.R. Factor XI deficiency, juvenile rheumatoid arthritis and systemic lupus erythematosus Report of the first case. Am J Med 63 2 (1977) 289-297
10. Krulik M., Tobelem G., Audebert A.A., Mougeot-Martin M., and Debray J. [Circulating anticoagulants in disseminated lupus erythematosus. Apropos of 3 cases]. Ann Med Interne (Paris) 128 1 (1977) 57-62
11. Vercellotti G.M., and Mosher D.F. Acquired factor XI deficiency in systemic lupus erythematosus. Thromb Haemost 48 3 (1982) 250-252
12. Aberg H., and Nilsson I.M. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta Med Scand 192 5 (1972) 419-425
13. Duran Jr. S., Vilaseca J., Ordeig J., and Triginer J. [Anti-factor XI circulating anticoagulant (author's transl)]. Sangre (Barc) 26 5-A (1981) 631-637
14. Duran-Suarez J.R., Bosch-Gil J.A., Pigrau-Serrallach C., and Ribera-Crusafont A. Anti-factor XI, direct positive Coombs's test and recurrent abortion in a systemic lupus erythematosus. Haematologica 66 3 (1981) 383-384
15. Bell W.R., Boss G.R., and Wolfson J.S. Circulating anticoagulant in the procainamide-induced lupus syndrome. Arch Intern Med 137 10 (1977) 1471-1473
16. Schnall S.F., Duffy T.P., and Clyne L.P. Acquired factor XI inhibitors in congenitally deficient patients. Am J Hematol 26 4 (1987) 323-328
17. Stern D.M., Nossel H.L., and Owen J. Acquired antibody to factor XI in a patient with congenital factor XI deficiency. J Clin Invest 69 6 (1982) 1270-1276
18. Musclow C.E., Amato D., Ofosu F., Armstrong A.L., and Abbott D. Transfusion-induced specific anti-factor XI inhibitor in a patient with previously unrecognized factor XI deficiency. Am J Clin Pathol 89 3 (1988) 418-422
19. Goldsmith Jr. G.H., and Silverman P. Inhibitors of plasma thromboplastin antecedent (factor XI): studies on mechanism of inhibition. J Lab Clin Med 106 3 (1985) 279-285
20. Fischer D.S., and Clyne L.P. Circulating factor XI antibody and disseminated intravascular coagulation. Arch Intern Med 141 4 (1981) 515-517
21. Bern M.M., Sahud M., Zhukov O., Qu K., and Mitchell Jr. W. Treatment of factor XI inhibitor using recombinant activated factor VIIa. Haemophilia 11 1 (2005) 20-25
22. Reece E.A., Clyne L.P., Romero R., and Hobbins J.C. Spontaneous factor XI inhibitors. Seven additional cases and a review of the literature. Arch Intern Med 144 3 (1984) 525-529
23. Hedner U. Factor VIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis 1 3 (1990) 307-317